457985AM1
Integra Lifesciences Holdings Corp
Could not find a ticker for this position, may be a filing error
A maker of surgical and medical devices used by neurosurgeons, reconstructive surgeons, and general surgeons. Its best-known product is the Integra Dermal Regeneration Template, a bioengineered "artificial skin" scaffold that helps severe burn victims grow new skin. The company was founded in 1989 by Dr. Richard Caruso, who licensed the collagen-scaffold technology developed at MIT and Harvard. Its name reflects the product's purpose: the matrix integrates with the patient's own body to regenerate tissue.
CONVERTIBLEUnderlying: IARTCUSIP: 457985AM1HealthcareUS1 derivative reporter
0.50% Convertible Senior Notes due August 15, 2025
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
